Of recent interest is the possibility that increased activity of the AMP-activated protein kinase (AMPK)-related kinase, NUAK1, in AD and primary tauopathies, results in the specific phosphorylation of tau at Ser356 [37]. Here, MAPT is linked to Alzheimer disease.